Global Idiopathic Pulmonary Fibrosis Management Market to Reach USD 3,850.1 Million by 2035 Amidst Steady Advances in Therapy and Diagnosis | FMI

The global idiopathic pulmonary fibrosis management market is poised for moderate yet consistent growth, with its valuation projected to rise from USD 3,252.8 million in 2025 to USD 3,850.1 million by 2035, reflecting a CAGR of 1.7% during the forecast period. The market’s expansion is underpinned by an increasing global burden of IPF, accelerated innovation …

Global Transfusion Dependent Thalassaemia Management Market to Reach USD 21.5 Million by 2035, Driven by Breakthroughs in Gene Therapy and Iron Chelation Treatments | FMI

The global transfusion dependent thalassaemia management market is on a steady growth trajectory, projected to rise from USD 11.2 million in 2025 to USD 21.5 million by 2035, at a robust compound annual growth rate (CAGR) of 6.5%. This expansion is largely driven by advancements in gene therapies, blood transfusion technologies, and iron chelation treatments, …

Global Ringworm Treatment Market Set to Surpass USD 15,106.66 Million by 2035 Amid Rising Fungal Infections and OTC Drug Accessibility | FMI

The global ringworm treatment market is poised for robust expansion, projected to grow from USD 9,274.18 million in 2025 to USD 15,106.66 million by 2035, reflecting a compound annual growth rate (CAGR) of 5% over the forecast period. This growth is largely fueled by a surge in fungal skin infections, rising consumer awareness around personal …

Global Aarskog-Scott Syndrome Treatment Market Set to Surge to USD 6.4 Billion by 2035, Driven by Genetic Innovations and Personalized Care | FMI

The global aarskog-scott syndrome treatment market is witnessing a transformative phase, with technological breakthroughs, personalized therapeutic strategies, and government-backed research initiatives reshaping patient care. As the healthcare industry turns its attention to rare genetic disorders, the Aarskog-Scott Syndrome (AAS) treatment market is projected to grow from USD 3.6 billion in 2025 to USD 6.4 billion …

Global Acrocallosal Syndrome Therapeutics Market Poised for Significant Growth, Projected to Reach USD 488.3 Million by 2035

The global acrocallosal syndrome therapeutics market a rare and complex genetic disorder characterized by agenesis of the corpus callosum, polydactyly, and distinct craniofacial anomalies—is set to experience transformative growth over the next decade. According to recent market analysis, the ACS therapeutics market is projected to rise from USD 181.5 million in 2025 to approximately USD …

Global Adrenogenital Syndrome Treatment Market to Reach USD 24.5 Billion by 2035, Driven by Technological Advancements and Rising Awareness | FMI

The global adrenogenital syndrome treatment market is poised for sustained growth, expected to expand from USD 14.2 billion in 2025 to USD 24.5 billion by 2035, registering a compound annual growth rate (CAGR) of 5.6% over the forecast period. The robust growth trajectory is attributed to technological innovations, rising disease awareness, improved diagnostics, and significant …

Global Abetalipoproteinemia Management Market Poised for Steady Growth Amid Rising Focus on Rare Disease Diagnosis and Treatment Innovations | FMI

The global abetalipoproteinemia management market is experiencing steady momentum as advancements in diagnostic technologies and treatment strategies meet the growing demand for specialized care for this ultra-rare lipid metabolism disorder. Although the condition affects a very limited population, increased awareness, early detection, and innovations in personalized medicine are propelling notable market expansion. Abetalipoproteinemia, a rare …

Global Alcohol Use Disorder Treatment Market Poised for Robust Growth: Projected to Reach USD 1.4 Billion by 2035

The global alcohol use disorder treatment market is entering a period of significant expansion, driven by increasing mental health awareness, advancements in addiction treatment, and proactive government advocacy for alcohol recovery programs. The market, currently valued at USD 0.79 billion in 2025, is projected to grow to USD 1.4 billion by 2035, registering a steady …

Global Biosensors Market Poised for Robust Growth to Reach USD 76.2 Billion by 2035 at a CAGR of 9.1% | Future Market Insights, Inc.

The global biosensors market is on an impressive growth trajectory, with its valuation expected to reach USD 31.8 billion in 2025 and soar to USD 76.2 billion by 2035, expanding at a Compound Annual Growth Rate (CAGR) of 9.1% during the forecast period. This robust expansion is driven by the increasing demand for rapid and …

Global Babesiosis Treatment Market Set to Soar with Technological Advancements and Increasing Tick-Borne Infections | FMI

The global babesiosis treatment market is expected to witness significant growth over the next decade, fueled by rising infection rates, especially in tick-endemic regions, and ongoing innovation in diagnostic methods and therapies. With an anticipated CAGR of 5.1% from 2025 to 2035, the market is projected to expand from a value of USD 1.35 billion …